Aarey Ebitda from 2010 to 2024
| AAREYDRUGS | 58.17 0.21 0.36% |
EBITDA | First Reported 2008-03-31 | Previous Quarter 27.5 M | Current Value 37.4 M | Quarterly Volatility 12.6 M |
Check Aarey Drugs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aarey Drugs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.6 M, Selling General Administrative of 3.5 M or Selling And Marketing Expenses of 1.6 M, as well as many indicators such as . Aarey financial statements analysis is a perfect complement when working with Aarey Drugs Valuation or Volatility modules.
Aarey | Ebitda |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Aarey Stock Analysis
When running Aarey Drugs' price analysis, check to measure Aarey Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarey Drugs is operating at the current time. Most of Aarey Drugs' value examination focuses on studying past and present price action to predict the probability of Aarey Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarey Drugs' price. Additionally, you may evaluate how the addition of Aarey Drugs to your portfolios can decrease your overall portfolio volatility.